State Street’s Mesoblast MESO Stock Holding History

State Street’s Portfolio MESO Stock Details MESO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-115,000	Closed	-$757K	–	4712
2023 Q1	$757K	Buy	+115,000	New	+$761K	﹤0.01%	3615
2021 Q3	–	Sell	-45,000	Closed	-$673K	–	4697
2021 Q2	$673K	Buy	+45,000	New	+$706K	﹤0.01%	3749
2021 Q1	–	Sell	-27,500	Closed	-$469K	–	3980
2020 Q4	$469K	Hold	27,500	–	–	﹤0.01%	3657
2020 Q3	$1.02M	Buy	27,500 +4,987	+22%	+$156K	﹤0.01%	3428
2020 Q2	$513K	Buy	+22,513	New	+$482K	﹤0.01%	3539

Other funds holding MESO

Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

LCM

Lazari Capital Management Woodland Hills, California $287M AUM 28.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street's MESO Position: Q2 2023 in Review

State Street sold out of Mesoblast (MESO) in Q2 2023, closing a stake of 115,000 shares — an estimated $757K sold.

State Street first reported a position in MESO in Q2 2020 and held it in 5 quarters. The position peaked at $1.02M in Q3 2020. 43 funds tracked by Wall St. Rank hold MESO as of Q2 2023.

State Street reported no remaining Mesoblast position as of Q2 2023 after selling out during the quarter.
State Street sold 115,000 Mesoblast shares in Q2 2023, an estimated $757K.
State Street first reported a position in Mesoblast in Q2 2020 and held it in 5 quarters.
State Street's Mesoblast position peaked at $1.02M in Q3 2020.
43 funds tracked by Wall St. Rank held Mesoblast as of Q2 2023.

Based on State Street's 13F filing for Q2 2023, filed 14 Aug 2023.